代谢与减重手术后长达19年的患者报告结局:单中心随访研究
该单中心前瞻性随访研究纳入559例2006至2025年间接受腹腔镜袖状胃切除术或Roux-en-Y胃旁路术的成人患者,174例完成多维度问卷。中位随访10年,87.7%对手术结果满意,90.6%愿再次手术,89.9%愿推荐代谢与减重手术,体重减轻幅度是感知成功的最强决定因素。
要点
- 代谢与减重手术后长达19年随访中,患者满意度、生活质量及工作能力改善持续存在。
- 体重减轻幅度越大,满意度、自信心、生活质量及BAROS、BQL评分越高。
- 就业状态未显著改变,但体重和情绪相关的工作限制明显改善。
核心结论
- 代谢与减重手术与术后长达19年持续的高满意度、改善的生活质量及更好的功能性工作能力相关。
- 体重减轻反应是患者感知手术成功的最强决定因素。
研究设计与样本
- 单中心前瞻性随访研究,纳入2006至2025年间在英国NHS Lothian接受腹腔镜袖状胃切除术或Roux-en-Y胃旁路术的成人患者。
- 559例符合条件患者中174例完成多维度随访问卷,中位随访10年,51.1%随访至少10年。
主要发现
- 受访者中女性占78.2%,中位年龄48岁,52.3%接受腹腔镜袖状胃切除术,47.7%接受Roux-en-Y胃旁路术。
- 中位总体重减轻23.7%,75.9%达到超过50%的超重体重减轻。
- 87.7%对手术结果满意,90.6%愿再次接受手术,89.9%愿推荐代谢与减重手术,中位满意度评分9.5/10。
- 84.1%报告自信心改善,89.9%报告生活质量改善,中位BAROS评分3.50提示结局良好,平均BQL评分49.7±8.41。
- 更大的体重减轻与更高的满意度、改善的自信心、改善的生活质量及更高的BAROS和BQL评分显著相关;结局在性别、年龄、手术方式、随访时长及糖尿病状态间大致相当。
临床怎么用
- 长期随访中应关注患者报告结局,包括满意度、生活质量及工作能力,而不仅限于体重指标。
- 体重减轻幅度可作为预测患者感知手术成功的重要参考。
局限性
- 单中心研究,559例符合条件患者中仅174例完成多维度随访问卷,可能存在应答偏倚。
- 原文未报告失访原因及未应答者与应答者的比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Metabolic and bariatric surgery (MBS) is an established treatment for severe obesity, yet data on very long-term patient-reported outcomes remain limited. This study assessed satisfaction, quality of life (QoL), perceived postoperative benefit, and work-related function up to 19 years after MBS. METHODS: This single-centre prospective follow-up study included adults who underwent laparoscopic sleeve gastrectomy (LSG) or Roux-en-Y gastric bypass (RYGB) at NHS Lothian, between 2006 and 2025. Patient-reported outcomes were evaluated using structured satisfaction questionnaires, the Bariatric Analysis and Reporting Outcome System (BAROS), the Bariatric Quality of Life index (BQL), benefit-ranking measures, and employment-related questionnaires. Outcomes were compared across demographic, socioeconomic, clinical, procedural, and weight-loss subgroups. RESULTS: Among 559 eligible patients, 174 completed multidomain follow-up questionnaires. Respondents were predominantly female (78.2%), with a median age of 48 years and median follow-up of 10 years; 51.1% had follow-up of at least 10 years. Overall, 52.3% underwent LSG and 47.7% underwent RYGB. Median total weight loss was 23.7%, and 75.9% achieved greater than 50% excess weight loss. Satisfaction was high: 87.7% were satisfied with their surgical outcome, 90.6% would undergo surgery again, and 89.9% would recommend MBS. Median satisfaction score was 9.5/10. Improved self-confidence and QoL were reported by 84.1% and 89.9% of patients, respectively. Median BAROS score was 3.50, indicating a good outcome, and mean BQL score was 49.7 ± 8.41. Greater weight loss was significantly associated with higher satisfaction, improved self-confidence, improved QoL, and higher BAROS and BQL scores. Outcomes were broadly comparable by sex, age, procedure type, follow-up duration, and diabetes status. Employment status did not significantly change, but weight and emotion-related work limitations improved substantially after surgery. CONCLUSION: MBS was associated with sustained long-term satisfaction, improved QoL, and better functional work capacity up to 19 years after surgery. Weight-loss response was the strongest determinant of perceived success.
引用
- Quaba M, Mitchell S, Knauf J, et al. Life following metabolic and bariatric surgery: up to 19 years follow-up, results from a tertiary centre. Surg Endosc. 2026. PMID: 42581202. doi:10.1007/s00464-026-13259-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。